For some of the acquisition reported in IBO over the last year, purchase prices were not available at the time of the announcement. The table below shows the prices for acquired companies that were later disclosed in regulatory filings or company reports.

Bio-Rad Laboratories also disclosed in its third-quarter regulatory filing that it paid $5 million in cash for Propel Lab’s cell sorting system and that the full purchase price includes $44.6 million in contingent considerations.

 Initially Undisclosed Purchase Prices 

 Purchaser              Acquired                               Purchase Price($M)        IBO Issue

 Accelrys               HEOS software                                 $4.5                5/31/12

 Bio-Rad Laboratories   Propel Labs's cell sorting system            $49.5               10/31/12

 Bruker                 SkyScan                                      $24.6                4/15/12

 Harvard Bioscience     AHN Biotechnologie                            $2.0                4/30/12

 Illumina               BlueGnome                                    $95.5                9/30/12

 INFICON                Photovac                                      $3.5               11/30/11

 Merck KGaA             Amnis                                        $77.3                8/31/11

 Pall                   ForteBio                                    $157.8               12/31/11

 Waters                 Baehr Thermoanalyse                          $12.0                2/29/12